TYK352: Difference between revisions
Jump to navigation
Jump to search
https://pedsanesthesia.net/wikiOLD032021>TYK bot (Bot: Automated import of articles) |
m (1 revision imported) |
(No difference)
| |
Latest revision as of 16:49, 20 March 2021
What is the most significant risk factor for cardiotoxicity from doxorubicin?
a) Dose of Doxorubicin
b) Duration of therapy
c) Family history
d) Patient age
Click for Answer
Answer
Answer a. Anthracycline cardiotoxicity is a lifetime cumulative dose-related side effect. Total lifetime dose should be monitored. In addition, serial echocardiography is important to monitor for cardiotoxicity, which may occur years following therapy.
Notes
- This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.